Fineline Cube

Follow:
14422 Articles
Milestone Biotechnologies Secures Nearly 100 Million Yuan in Series A+ Funding
Company

Milestone Biotechnologies Secures Nearly 100 Million Yuan in Series A+ Funding

AstraZeneca's Tagrisso Receives NMPA Approval for EGFR-Mutated NSCLC Treatment
CompanyDrug

AstraZeneca’s Tagrisso Receives NMPA Approval for EGFR-Mutated NSCLC Treatment

NMPA Approves Lynparza as Adjuvant Treatment for High-Risk Breast Cancer Patients
CompanyDrug

NMPA Approves Lynparza as Adjuvant Treatment for High-Risk Breast Cancer Patients

Gilead Sciences' Sunlenca Receives NMPA Approval for Multidrug-Resistant HIV-1 Infection
CompanyDrug

Gilead Sciences’ Sunlenca Receives NMPA Approval for Multidrug-Resistant HIV-1 Infection

WinHealth Pharma's Difelikefalin Receives NMPA Review for Market Approval
CompanyDrug

WinHealth Pharma’s Difelikefalin Receives NMPA Review for Market Approval

Shanghai Enacts New Regulations for Drug and Medical Device Administration
Policy / Regulatory

Shanghai Enacts New Regulations for Drug and Medical Device Administration

Thederma's TAN-118 Receives Tacit Clinical Approval from China's CDE for Global Trials
CompanyDrug

Thederma’s TAN-118 Receives Tacit Clinical Approval from China’s CDE for Global Trials

Shenzhen Hepalink Pharmaceuticals to Distribute Gabapentin in US under New Agreement
CompanyDeals

Shenzhen Hepalink Pharmaceuticals to Distribute Gabapentin in US under New Agreement

Innovent Biologics' Taletrectinib Gains NMPA Approval for ROS1 Positive NSCLC
CompanyDrug

Innovent Biologics’ Taletrectinib Gains NMPA Approval for ROS1 Positive NSCLC

MabPharm's CMAB807 Biosimilar Infliximab Approved in Pakistan
CompanyDrug

MabPharm’s CMAB807 Biosimilar Infliximab Approved in Pakistan

Zhaoke Ophthalmology's NVK002 ANDA Accepted for Review by China's NMPA
CompanyDrug

Zhaoke Ophthalmology’s NVK002 ANDA Accepted for Review by China’s NMPA

Grand Pharmaceutical Initiates Study on GPN00289 for Liver Cancer Treatment
CompanyMedical Device

Grand Pharmaceutical Initiates Study on GPN00289 for Liver Cancer Treatment